Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elizabeth E. Sugg
Observed names:
E E Sugg,
E Sugg,
E. E. SUGG,
E. SUGG,
E. Sugg,
E.E. Sugg,
ELIZABETH E. SUGG,
Elizabeth E Sugg
show all 8
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
University of Minnesota,
Mayo Clinic,
Vrije Universiteit Brussel,
University of Arizona,
Vanderbilt University,
Brown University,
GlaxoSmithKline (United States),
Mayo Clinic in Arizona,
Duke Medical Center,
Virginia Tech
show all 11
OpenAlex ID:
A5017853209
Allele-specific activation of genetically engineered receptors.
1991
·
C D Strader
, T Gaffney
, et al.
·
Journal of Biological Chemistry
·
228
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
1996
·
Christopher J. Aquino
, Duncan R. Armour
, et al.
·
Journal of Medicinal Chemistry
·
100
Determination of the three-dimensional structure of iberiotoxin in solution by proton nuclear magnetic resonance spectroscopy
1992
·
Bruce A. Johnson
, Elizabeth E. Sugg
·
Biochemistry
·
92
Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists
1997
·
Brad R. Henke
, Christopher J. Aquino
, et al.
·
Journal of Medicinal Chemistry
·
85
Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels
1993
·
Kathleen M. Giangiacomo
, Elizabeth E. Sugg
, et al.
·
Biochemistry
·
80
Synthesis and structural characterization of charybdotoxin, a potent peptidyl inhibitor of the high conductance Ca2(+)-activated K+ channel.
1990
·
E.E. Sugg
, M.L. Garcia
, et al.
·
Journal of Biological Chemistry
·
70
Synthesis and Evaluation of Potent and Selective β3 Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres
2001
·
David E. Uehling
, Kelly H. Donaldson
, et al.
·
Journal of Medicinal Chemistry
·
63
Influence of pseudoallylic strain on the conformational preference of 4-methyl-4-phenylpipecolic acid derivatives
1985
·
Elizabeth E. Sugg
, Jane F. Griffin
, et al.
·
The Journal of Organic Chemistry
·
57
Rapid optimization of enzyme substrates using defined substrate mixtures.
1992
·
J Berman
, M Green
, et al.
·
Journal of Biological Chemistry
·
51
Novel Benzodiazepine Photoaffinity Probe Stereoselectively Labels a Site Deep within the Membrane-Spanning Domain of the Cholecystokinin Receptor
2006
·
Elizabeth M. Hadac
, Eric S. Dawson
, et al.
·
Journal of Medicinal Chemistry
·
47
Biarylaniline Phenethanolamines as Potent and Selective β3Adrenergic Receptor Agonists
2006
·
David E. Uehling
, Barry G. Shearer
, et al.
·
Journal of Medicinal Chemistry
·
40
Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent
1996
·
Gavin C. Hirst
, Christopher Aquino
, et al.
·
Journal of Medicinal Chemistry
·
37
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens
1994
·
Anthony J. Conley
, Patricia Conard
, et al.
·
Vaccine
·
34
An Improved Synthesis and Resolution of 3-Amino-1,3-dihydro-5-phenyl-2H- 1,4-benzodiazepin-2-ones
1995
·
Ronald G. Sherrill
, Elizabeth E. Sugg
·
The Journal of Organic Chemistry
·
31
Cyclic lactam analogs of Ac-[Nle4].alpha.-MSH4-11-NH2
1988
·
Elizabeth E. Sugg
, Ana Maria De L. Castrucci
, et al.
·
Biochemistry
·
30
1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists
2001
·
Ronald G Sherrill
, Judd M Berman
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
29
3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents
1996
·
Brad R. Henke
, Timothy M. Willson
, et al.
·
Journal of Medicinal Chemistry
·
29
D ‐Isomeric replacements within the 6–9 core sequence of ac‐[Nle4]‐α‐MSH4–11‐NH2: A topological model for the solution conformation of α‐melanotropin
1986
·
Elizabeth E. Sugg
, Wayne L. Cody
, et al.
·
Biopolymers
·
27
3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists
1996
·
Timothy M. Willson
, Brad R. Henke
, et al.
·
Journal of Medicinal Chemistry
·
23
Chapter 28. Nonpeptide Agonists for Peptide Receptors: Lessons from Ligands
1997
·
Elizabeth E. Sugg
·
Annual reports in medicinal chemistry
·
19
Proton n.m.r. investigation of conformational influence of penicillamine residues on the disulfide ring system of opioid receptor selective Somatostatin derivatives
1988
·
ELIZABETH E. SUGG
, DIRK TOURWE
, et al.
·
International journal of peptide & protein research
·
19
Proton n.m.r. spectroscopic evidence for sulfur‐aromatic interactions in peptides
1987
·
MICHAL LEBL
, ELIZABETH E. SUGG
, et al.
·
International journal of peptide & protein research
·
19
Structurally similar small molecule photoaffinity CCK-A agonists and antagonists as novel tools for directly probing 7TM receptor-ligand interactions
1998
·
James W. Darrow
, Elizabeth M. Hadac
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
16
Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands
1995
·
Milana Dezube
, Elizabeth E. Sugg
, et al.
·
Journal of Medicinal Chemistry
·
16
A further analysis of the contraction induced by activation of cholecystokinin A receptors in guinea pig isolated ileum longitudinal muscle-myenteric plexus.
1994
·
M Corsi
, S Palea
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
13
Show more works
View as search
Works count:
48
Citation count:
1,323
H-index:
19
I10-index:
26
Year
Topic
Type
